Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome
Abstract Background Homocysteine metabolism is altered in children with idiopathic nephrotic syndrome. Hyperhomocysteinemia is a risk factor of early atherosclerosis and glomerulosclerosis and may occur at time of first occurrence of idiopathic nephrotic syndrome. Methods Thirty children with first...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-04-01
|
Series: | Clinical and Translational Science |
Subjects: | |
Online Access: | https://doi.org/10.1111/cts.12145 |
id |
doaj-f11202583034401b8a61ead3bac7ae4d |
---|---|
record_format |
Article |
spelling |
doaj-f11202583034401b8a61ead3bac7ae4d2020-11-25T02:37:06ZengWileyClinical and Translational Science1752-80541752-80622014-04-017213213610.1111/cts.12145Homocysteine Metabolism in Children with Idiopathic Nephrotic SyndromeMohan Kundal0Abhijeet Saha1N.K. Dubey2Kanika Kapoor3Trayambak Basak4Gaurav Bhardwaj5Vinay Singh Tanwar6Shantanu Sengupta7Vinita Batra8Ashish Dutt Upadhayay9Ajay Bhatt10Division of Pediatric Nephrology, Department of Pediatrics Postgraduate Institute of Medical Education and Research associated Dr. Ram Manohar Lohia Hospital New Delhi IndiaCSIR‐Institute of Genomics and Integrative Biology New Delhi IndiaDepartment of Pathology GB Pant Hospital New Delhi IndiaDepartment of Biostatistics AIIMS New Delhi IndiaCSIR‐Institute of Genomics and Integrative Biology New Delhi IndiaCSIR‐Institute of Genomics and Integrative Biology New Delhi IndiaCSIR‐Institute of Genomics and Integrative Biology New Delhi IndiaCSIR‐Institute of Genomics and Integrative Biology New Delhi IndiaDepartment of Pathology GB Pant Hospital New Delhi IndiaDepartment of Biostatistics AIIMS New Delhi IndiaCSIR‐Institute of Genomics and Integrative Biology New Delhi IndiaAbstract Background Homocysteine metabolism is altered in children with idiopathic nephrotic syndrome. Hyperhomocysteinemia is a risk factor of early atherosclerosis and glomerulosclerosis and may occur at time of first occurrence of idiopathic nephrotic syndrome. Methods Thirty children with first episode of idiopathic nephrotic syndrome (FENS) aged 1–16 years along with 30 age‐ and sex‐matched healthy controls were enrolled in this study. Homocysteine and cysteine were measured with HPLC; vitamin B12 and folic acid were measured with electro‐chemilumiscence immunoassay. Primary outcome measure was plasma homocysteine level in children with FENS and in controls. Secondary outcome measures were (1) plasma and urine homocysteine and cysteine levels in children with FENS at 12 weeks and 1 year (remission) and (2) plasma and urine levels of vitamin B12 and folic acid in children with FENS, at 12 weeks and 1 year (remission). Results Plasma homocysteine and cysteine levels were comparable to controls in children with FENS, at 12 weeks and 1‐year remission. Plasma levels of vitamin B12 and folic acid were significantly decreased compared to controls in FENS due to increased urinary excretion, which normalize during remission at 12 weeks and 1 year. Urinary homocysteine and cysteine levels were significantly raised in FENS compared to controls and continued to be raised even at 12‐week and 1‐year remission. Conclusion Homocysteine metabolism is deranged in children with FENS. Renal effects of long‐term raised urinary homocysteine levels need to be studied.https://doi.org/10.1111/cts.12145homocysteinechildrennephrotic syndrome |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mohan Kundal Abhijeet Saha N.K. Dubey Kanika Kapoor Trayambak Basak Gaurav Bhardwaj Vinay Singh Tanwar Shantanu Sengupta Vinita Batra Ashish Dutt Upadhayay Ajay Bhatt |
spellingShingle |
Mohan Kundal Abhijeet Saha N.K. Dubey Kanika Kapoor Trayambak Basak Gaurav Bhardwaj Vinay Singh Tanwar Shantanu Sengupta Vinita Batra Ashish Dutt Upadhayay Ajay Bhatt Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome Clinical and Translational Science homocysteine children nephrotic syndrome |
author_facet |
Mohan Kundal Abhijeet Saha N.K. Dubey Kanika Kapoor Trayambak Basak Gaurav Bhardwaj Vinay Singh Tanwar Shantanu Sengupta Vinita Batra Ashish Dutt Upadhayay Ajay Bhatt |
author_sort |
Mohan Kundal |
title |
Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome |
title_short |
Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome |
title_full |
Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome |
title_fullStr |
Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome |
title_full_unstemmed |
Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome |
title_sort |
homocysteine metabolism in children with idiopathic nephrotic syndrome |
publisher |
Wiley |
series |
Clinical and Translational Science |
issn |
1752-8054 1752-8062 |
publishDate |
2014-04-01 |
description |
Abstract Background Homocysteine metabolism is altered in children with idiopathic nephrotic syndrome. Hyperhomocysteinemia is a risk factor of early atherosclerosis and glomerulosclerosis and may occur at time of first occurrence of idiopathic nephrotic syndrome. Methods Thirty children with first episode of idiopathic nephrotic syndrome (FENS) aged 1–16 years along with 30 age‐ and sex‐matched healthy controls were enrolled in this study. Homocysteine and cysteine were measured with HPLC; vitamin B12 and folic acid were measured with electro‐chemilumiscence immunoassay. Primary outcome measure was plasma homocysteine level in children with FENS and in controls. Secondary outcome measures were (1) plasma and urine homocysteine and cysteine levels in children with FENS at 12 weeks and 1 year (remission) and (2) plasma and urine levels of vitamin B12 and folic acid in children with FENS, at 12 weeks and 1 year (remission). Results Plasma homocysteine and cysteine levels were comparable to controls in children with FENS, at 12 weeks and 1‐year remission. Plasma levels of vitamin B12 and folic acid were significantly decreased compared to controls in FENS due to increased urinary excretion, which normalize during remission at 12 weeks and 1 year. Urinary homocysteine and cysteine levels were significantly raised in FENS compared to controls and continued to be raised even at 12‐week and 1‐year remission. Conclusion Homocysteine metabolism is deranged in children with FENS. Renal effects of long‐term raised urinary homocysteine levels need to be studied. |
topic |
homocysteine children nephrotic syndrome |
url |
https://doi.org/10.1111/cts.12145 |
work_keys_str_mv |
AT mohankundal homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome AT abhijeetsaha homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome AT nkdubey homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome AT kanikakapoor homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome AT trayambakbasak homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome AT gauravbhardwaj homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome AT vinaysinghtanwar homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome AT shantanusengupta homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome AT vinitabatra homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome AT ashishduttupadhayay homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome AT ajaybhatt homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome |
_version_ |
1724796694271361024 |